Marques, Rodolfo Ferreira 
; Gimenez, Alba Marina ; Caballero, Otávia; Simpson, Andrew; Salazar, Andres M; Amino, Rogerio ; Godin, Steven; Gazzinelli, Ricardo T, ; Soares, Irene da Silva
Fonte: Vaccine. Unidades: ICB, FCF
Assuntos: MALÁRIA, VACINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Rodolfo Ferreira et al. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, v. 42, n. 9, p. 2394-2406, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vaccine.2024.02.070. Acesso em: 19 jul. 2024.APA
Marques, R. F., Gimenez, A. M., Caballero, O., Simpson, A., Salazar, A. M., Amino, R., et al. (2024). Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, 42( 9), 2394-2406. doi:10.1016/j.vaccine.2024.02.070NLM
Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 jul. 19 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070Vancouver
Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 jul. 19 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070
